Tag Archives: Abraham Heifets

February 22, 2022
Sold on the New Machine
In The News
Read Article
July 23, 2019
What’s Your Moonshot? Abraham Heifets of Atomwise Is Using AI to Speed up the Development of Medications Targeted at Specific Cancer Cells
In The News

Noah Miller of Newsweek interviews Abraham Heifets, Atomwise CEO, about his Moonshot.

Read Article
June 4, 2019
Time For AI To Deliver In Drug Discovery, Says Atomwise CEO
In The News

Having signed a multi-year, multi-target agreement with Lilly worth potentially $550m, Atomwise CEO Abe Heifets tells Scrip the burden of proof is on AI practitioners to start producing relevant and actionable data.

Read Article